Browsing Tag
ALTITUDE-AD
1 post
Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure
Acumen Pharmaceuticals stock plunges 88% after its Alzheimer's trial fails. Explore its $78.6M cash position and strategic options.